Westmead Hospital

Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer (2021) Quinn MC, McCue K, Shi W, Johnatty SE, Beesley J, Civitarese A, O'Mara TA, et al. Journal article Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers (2021) Glubb DM, Thompson DJ, Aben KKH, Alsulimani A, Amant F, Annibali D, Attia J, et al. Journal article KEYNOTE-522 Asian subgroup: Phase III study of neoadjuvant pembrolizumab (pembro) vs placebo (pbo) plus chemotherapy (chemo) followed by adjuvant pembro vs pbo for early triple-negative breast cancer (TNBC) (2020) Dent R, Cortes J, Pusztai L, Mcarthur HL, Kuemmel S, Bergh J, Denkert C, et al. Conference contribution Clinical characteristics and outcomes of coronavirus 2019 disease (COVID-19) in cancer patients treated with immune checkpoint inhibitors (ICI). (2020) Rogiers A, Tondini C, Grimes JM, Trager MH, Nahm S, Zubiri L, Papneja N, et al. Conference contribution Collective forces of tumor spheroids in three-dimensional biopolymer networks (2020) Mark C, Grundy TJ, Strissel P, Böhringer D, Grummel N, Gerum R, Steinwachs J, et al. Journal article Collective Synchronization of Contractile Forces in Tumor Spheroids (2020) Böhringer D, Mark C, Grummel N, Strissel P, Strick R, Grundy TJ, O'Neill GM, Fabry B Conference contribution Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT (2020) Schmidt-Hieber M, Engelhard D, Ullmann A, Ljungman P, Maertens J, Martino R, Rovira M, et al. Journal article Correction: Collective forces of tumor spheroids in three-dimensional biopolymer networks. (2020) Mark C, Grundy TJ, Strissel P, Böhringer D, Grummel N, Gerum R, Steinwachs J, et al. Journal article, Erratum Prognostic gene expression signature for high-grade serous ovarian cancer (2020) Millstein J, Budden T, Goode EL, Anglesio MS, Talhouk A, Intermaggio MP, Leong HS, et al. Journal article KEYNOTE-522: Phase III study of pembrolizumab (pembro) plus chemotherapy (chemo) vs placebo (pbo) plus chemo as neoadjuvant treatment, followed by pembro vs pbo as adjuvant treatment for early triple-negative breast cancer (TNBC) (2019) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur HL, Kuemmel S, Bergh J, et al. Conference contribution